Studies have shown that chronic central leptin infusion can reduce hepatic lipid synthesis gene expression and triglyceride levels by stimulating hepatic sympathetic activity and that this effect of leptin is associated with the PI3K signaling pathway, blocking which can specifically induce hepatic steatosis without causing obesity. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.